Trial
NCT06139796
Pharmacokinetics Safety and Acceptability of DRV/r for Children Living With HIV
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
PENTA Foundation
Collaborators
AMS-PHPT Research Collaboration; Institut National de la Santé Et de la Recherche Médicale, France; Centre Mère et Enfant de la Fondation Chantal Biya; Centre Hospitalier National d'Enfants Albert Royer; University of Zimbabwe Clinical Research Centre (UZCRC); Baylor College of Medicine
Condition
HIV Infections
Intervention
DRV/r FDC (120/20mg)
Why stopped
Study not started as the IMP is re-worked by the manufacturer
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-05